Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3706811
Max Phase: Preclinical
Molecular Formula: C30H39FN4O
Molecular Weight: 490.67
Molecule Type: Small molecule
Associated Items:
ID: ALA3706811
Max Phase: Preclinical
Molecular Formula: C30H39FN4O
Molecular Weight: 490.67
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1[nH]c2cc(NC(=O)N[C@@H]3CCCC[C@H]3CN3CCC[C@@H](Cc4ccc(F)cc4)C3)ccc2c1C
Standard InChI: InChI=1S/C30H39FN4O/c1-20-21(2)32-29-17-26(13-14-27(20)29)33-30(36)34-28-8-4-3-7-24(28)19-35-15-5-6-23(18-35)16-22-9-11-25(31)12-10-22/h9-14,17,23-24,28,32H,3-8,15-16,18-19H2,1-2H3,(H2,33,34,36)/t23-,24-,28+/m0/s1
Standard InChI Key: QJHXQMJXEVMHTH-IBGGVINMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 490.67 | Molecular Weight (Monoisotopic): 490.3108 | AlogP: 6.56 | #Rotatable Bonds: 6 |
Polar Surface Area: 60.16 | Molecular Species: BASE | HBA: 2 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.16 | CX Basic pKa: 10.02 | CX LogP: 6.33 | CX LogD: 3.76 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.37 | Np Likeness Score: -1.25 |
1. De Lucca GV, Kim UT, Vargo BJ, Duncia JV, Santella JB, Gardner DS, Zheng C, Liauw A, Wang Z, Emmett G, Wacker DA, Welch PK, Covington M, Stowell NC, Wadman EA, Das AM, Davies P, Yeleswaram S, Graden DM, Solomon KA, Newton RC, Trainor GL, Decicco CP, Ko SS.. (2005) Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency., 48 (6): [PMID:15771462] [10.1021/jm049530m] |
Source(1):